. PON2 also has antioxidative properties and we show that it protects cells from pyocyanin-induced oxidative stress. Knockdown of PON2 by transfecting cells with siRNA (small interfering RNA) rendered them more sensitive to, whereas overexpression of PON2 protected cells from, pyocyanin-induced ROS formation. Additionally, 3OC12 potentiated pyocyanininduced ROS formation, presumably by inactivating PON2. These findings support a key role for PON2 in the defence against Ps. aeruginosa virulence, but also reveal a mechanism by which the bacterium may subvert the protection afforded by PON2.
Two virulence factors produced by Pseudomonas aeruginosa are pyocyanin and N-(3-oxododecanoyl)-L-homoserine lactone (3OC12). Pyocyanin damages host cells by generating ROS (reactive oxygen species)
. 3OC12 is a quorum-sensing signalling molecule which regulates bacterial gene expression and modulates host immune responses. PON2 (paraoxonase-2) is an esterase that inactivates 3OC12 and potentially attenuates Ps. aeruginosa virulence. Because increased intracellular Ca 2+ initiates the degradation of PON2 mRNA and protein and 3OC12 causes increases in cytosolic Ca 2+ , we hypothesized that 3OC12 would also down-regulate PON2. 3OC12 and the Ca 2+ ionophore A23187 caused a rapid cytosolic Ca 2+ influx and down-regulated PON2 mRNA, protein and hydrolytic activity in A549 and EA.hy 926 cells. The decrease in PON2 hydrolytic activity was much more extensive and rapid than decreases in protein, suggesting a rapid post-translational mechanism which blocks PON2's hydrolytic activity. The Ca 2+ chelator BAPTA/AM [1,2-bis-(o-aminophenoxy)ethane-N,N,N ,N -tetraacetic acid tetrakis(acetoxymethyl ester)] diminished the ability of 3OC12 to decrease PON2, demonstrating that the effects are mediated by Ca 2+ . PON2 also has antioxidative properties and we show that it protects cells from pyocyanin-induced oxidative stress. Knockdown of PON2 by transfecting cells with siRNA (small interfering RNA) rendered them more sensitive to, whereas overexpression of PON2 protected cells from, pyocyanin-induced ROS formation. Additionally, 3OC12 potentiated pyocyanininduced ROS formation, presumably by inactivating PON2. These findings support a key role for PON2 in the defence against Ps. aeruginosa virulence, but also reveal a mechanism by which the bacterium may subvert the protection afforded by PON2.
INTRODUCTION
Pseudomonas aeruginosa is a common nosocomial pathogen which causes serious infections in immunocompromised individuals [1] . Two virulence factors produced by Ps. aeruginosa are the quorum-sensing signalling molecule N-(3-oxododecanoyl)-L-homoserine lactone (3OC12) and PCN (pyocyanin), a redox-active metabolite ( Figure 1 ) [2, 3] . 3OC12 is a key signalling molecule which regulates the cell-density-dependent expression of many Ps. aeruginosa virulence factors [3] . As the density of bacteria increase, the concentration of 3OC12 becomes high enough to effectively bind its cognate receptor and induce or repress gene expression. The importance of 3OC12 for Ps. aeruginosa pathogenicity has been demonstrated in many in vivo models. Rats and mice experimentally infected with Ps. aeruginosa mutants deficient in the ability to produce or respond to 3OC12 exhibited significantly diminished lung pathology, bacterial dissemination and morbidity [4] [5] [6] [7] [8] . Additionally, 3OC12 has a plethora of immunomodulatory effects on cells in vitro such as induction of apoptosis and pro-inflammatory mediators and inhibition of lymphocyte immune responses, suggesting that this molecule can compromise host defences (reviewed in [9] ). PCN production by Ps. aeruginosa is positively regulated by quorum-sensing signals including 3OC12 and it is expressed at high levels [2, 10] . PCN redox-cycles in the presence of reducing agents such as NADPH, forming the ROS (reactive oxygen species) superoxide and hydrogen peroxide [11] . ROS generated by PCN induces an array of damage to various cell types, which could favour bacterial colonization, including induction of neutrophil apoptosis, induction of interleukin-8 and inhibition of the dual-oxidase-based antimicrobial system in airway epithelial cells [12] [13] [14] . The necessity of PCN for full expression of Ps. aeruginosa virulence is exemplified by mutant bacterial strains deficient in PCN production which are more rapidly cleared from lungs of mice and are less able to cause pneumonia after intratracheal instillation [15] .
PONs (paraoxonases), a family of Ca 2+ -dependent esterases consisting of PON1, PON2 and PON3, were found to inactivate 3OC12, as well as other bacterial acyl-homoserine lactone signalling molecules, by hydrolysis of the lactone ring [16, 17] . The mammalian PONs are a unique highly conserved family [17] . PON1 and PON3 are predominantly expressed in the liver from where PON1 and some PON3 are secreted into the serum. PON2 is not found in serum but it is expressed in a wide range of tissues Abbreviations used: AEBSF, 4-(2-aminoethyl)benzenesulfonyl fluoride; AM, acetoxymethyl ester; BAPTA/AM, 1,2-bis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid tetrakis(acetoxymethyl ester); BCA, bicinchoninic acid; carboxy-H 2 DCFDA, 5-(and-6)-carboxy-2 ,7 -dichlorodihydrofluorescein diacetate; DMNQ, 2,3-dimethoxy-1,4-naphthoquinone; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; HA, haemagglutinin; HBSS ++ , Hanks balanced salt solution with CaCl 2 and MgCl 2 ; HRP, horseradish peroxidase; 3OC12, N-(3-oxododecanoyl)-L-homoserine lactone; PCN, pyocyanin; PON, paraoxonase; ROS, reactive oxygen species; siRNA, small interfering RNA. 1 To whom correspondence should be addressed (email john.teiber@utsouthwestern.edu). and cell types. The PONs hydrolyse a range of esters, including organophosphates, aromatic esters and lactones, and also have antioxidative properties; however, their physiological functions and natural substrates are uncertain. The ability of PONs to inactivate 3OC12 suggests that they may be an important mechanism by which the host attenuates Ps. aeruginosa virulence. Expression of human PON1 in transgenic Drosophilia melanogaster afforded protection from lethality after Ps. aeruginosa infection [18] . Although PON1 knockout (Pon1 −/− ) mice paradoxically had a higher rate of survival compared with the wild-type mice after intraperitoneal Ps. aeruginosa injection, PON2 and PON3 were shown to be upregulated in the Pon1 −/− mouse airway epithelia [16] . This led the authors to propose that up-regulation of PON2 and/or PON3 may have increased the inactivation of 3OC12 in the Pon1 −/− mice. PON2 is of particular interest as it has a high specific activity for 3OC12 [19] . PON2 is ubiquitously expressed and was found to be the major enzyme hydrolysing 3OC12 in mouse lung homogenates and in lysates from several types of mammalian cells [19] . Bronchial epithelial cells from PON2-deficient mice were less able than the wild-type cells to attenuate quorum-sensing by Ps. aeruginosa after infection of the cells [20] . Consistent with this, the lysates from the wild-type cells could inactivate 3OC12 at a much higher rate than the lysates from the PON2-deficient cells. However, paradoxically, in this same study, it was shown that the rate of inactivation of 3OC12 in intact PON2-deficient and wild-type epithelial cells was similar. This latter finding brings in to question the relevance of PON2 for the inactivation of 3OC12 in vivo and indicates that a better understanding of factors which may affect the activity or levels of PON2 or access of 3OC12 to the enzyme, which is intracellular, is needed.
We demonstrated recently that increased cellular Ca 2+ mediates the degradation of PON2 protein and mRNA [21] . Because 3OC12 can increase cytosolic Ca 2+ [22] , we hypothesized that 3OC12 may mediate decreases in PON2 mRNA and protein. Therefore, as our first objective, we investigated the ability of 3OC12 to regulate PON2 protein levels, mRNA and hydrolytic activity in cell cultures. We also demonstrated previously that PON2 can diminish the production of ROS generated by the redox-cycling compound DMNQ (2,3-dimethoxy-1,4-naphthoquinone) in several cell lines [23] . Given the ability of PCN to redox cycle and induce oxidative stress, we examined the ability of PON2 to attenuate the production of ROS by PCN in cell culture as our second objective. Because we found that 3OC12 down-regulated PON2 and that PON2 could protect cells for PCN-mediated ROS formation, we also investigated the ability of 3OC12 to potentiate ROS formation by PCN.
Studies were performed in human A549 cells, a lung epithelial carcinoma cell line, and EA.hy 926 cells, a human endothelial cell line, which are representative of those likely to be exposed to 3OC12 during Ps. aeruginosa lung and wound infections respectively [4] . 
Synthesis of 3OC12 and 3OC12 acid
L-3OC12 was synthesized by acid chloride acylation of Meldrum's acid (2,2-dimethyl-1,3-dioxane-4,6-dione) and subsequent reaction with L-homoserine lactone as described previously [19] . D-3OC12 was synthesized by the same method, but using D-homoserine lactone. Cell culture A549 cells were cultured with MEM (minimum essential medium) containing L-glutamine (Mediatech), penicillin/streptomycin (10 000 units/ml penicillin, 10 mg/ml streptomycin) (Invitrogen) and 10 % heat-inactivated FBS (fetal bovine serum) (Gemini) in a humidified atmosphere of 5 % CO 2 . The human umbilical vein endothelial cell-derived EA.hy 926 cells were cultured as described previously in a humidified atmosphere of 10 % CO 2 [23] .
Cell viability and caspase activity analysis A549 cells were seeded in 24 well plates at 10 5 cells/well. The following day they were treated with 100 μM 3OC12 in 0. 
Determination of PON2 hydrolytic activity
Cells were seeded in 12-well plates at a density of 2×10 5 cells/ well. Approx. 18 h later, 1 ml of fresh medium containing either 3OC12 or the ionophore A23187, from stock solutions in methanol, was added. Media for control and treatment groups contained 0.1 % methanol. For intracellular Ca 2+ chelation experiments, cells were treated with either DMSO, for controls, or BAPTA/AM from a 10 mM stock in DMSO. After 10 min, the medium was removed and fresh medium was added containing either 3OC12 or BAPTA/AM or both. Control cell medium contained methanol and DMSO at concentrations present in the treatment groups. At the end of the treatment, cells were rinsed briefly with trypsin and then detached with trypsin and pelleted. Cells were washed by resuspending the pellet in PBS, repelleting the cells and removing the PBS. Cell pellets were stored at −80
• C until use. To determine PON2 hydrolytic activity, frozen cell pellets were thawed and sonicated briefly on ice in lysis buffer; 25 mM Tris/HCl buffer (pH 7.4) containing 1 mM CaCl 2 , 0.05% ndodecyl-β-D-maltoside, 5 μg/ml leupeptin, 2 μg/ml aprotinin, 1 μg/ml pepstatin and 1 mM AEBSF. Lysates were centrifuged at 14 000 g for 2 min, and supernatants were analysed for protein concentration using the BCA (bicinchoninic acid) method (Pierce) and 3OC12 hydrolytic activity as described previously [19] with minor modifications described below.
Supernatants, or lysis buffer for controls, were added to 5 mM Tris/HCl buffer (pH 7.4) containing 1 mM CaCl 2 . Reactions, in 100 μl final volume, were initiated by adding a 1 % volume of a 5 mM 3OC12 stock solution (in methanol) and incubating at 37
• C. Reactions were stopped with 70 μl of ice-cold acetonitrile, placed on ice for 2 min, vortex-mixed and centrifuged at 14 000 g for 1 min to pellet the precipitated protein. Supernatants (20 μl) were chromatographed on a Shimadzu HPLC system equipped with a UV-visible detector, set a 205 nm, using a Restek Pinnacle II C 18 column (250 mm×4.6 mm, 5 μm particles). Samples were eluted isocratically with water/acetonitrile/acetic acid (28:72:0.2, by vol.) at 1 ml/min. Retention times for 3OC12 and the 3OC12 acid product were 5.7 and 3.7 min respectively. Initial hydrolysis rates were estimated under conditions in which less than 10 % of the substrate was hydrolysed.
For EDTA inhibition, A549 cells were sonicated in lysis buffer without CaCl 2 , but containing 0.5 mM EDTA and supernatants left overnight at 4 • C. Supernatants were then analysed for 3OC12 activity as described above, except that the reactions were performed in buffer without CaCl 2 .
siRNA (small interfering RNA) down-regulation of PON2
Cells were seeded in 24-well plates at a density of 60 % confluence. The next day, 50 nM PON2-specific siRNA (5 -TTAGTATTCCTCCAGGCTTATCTGG-3 ) or scrambled siRNA were transfected using Saint-Red reagent (Synvolux) according to the manufacturer's recommendations. At 3-4 days after treatment, PON2 protein knockdown was most efficient, and experiments were performed over this time period. PON2 protein levels were controlled in every experiment by parallel Western blotting using a subset of each group analysed. Stealth-siRNAs were purchased from Invitrogen.
Cytosolic Ca 2+ influx
Cells were seeded 1 day before the experiment with 1.5×10 4 cells/well in opaque (black) 96-well plates suited for fluorescence analyses (Greiner). Cells were loaded with 5 μM Fluo-4 AM in medium at 37
• C for 40 min. Then, cells were briefly washed in HBSS ++ and treated with medium containing solvent (0.1 % methanol; control) or 100 μM 3OC12 or 3OC12 acid. Fluorescence was measured immediately using a Fluostar Optima fluorimeter (BMG Labtechnologies) with excitation and emission wavelengths of 480 nm and 530 nm respectively. Samples were kept at 37
• C. Fluorescence was recorded every 1.3 s. Data were analysed by subtracting baseline values and normalizing to control-treated cells.
ROS induction by PCN
Cells were seeded in opaque 96-well plates with a density of 2×10 4 cells/well. The next day, medium was aspirated, cells were washed with HBSS ++ , loaded with 2.5 nM carboxy-H 2 DCFDA for 30 min at 37
• C, washed again and incubated with PCN in complete growth medium. Increase in fluorescence intensity, indicative of accumulating oxidative stress, was measured as above, but every 5 min for a total of 12 h. For studies with the luminol derivative L-012, after washing cells with HBSS ++ , they were incubated with 0.5 mM L-012 for 15 min at 37
• C before addition of PCN to the culture medium. ROS-induced chemiluminescence was determined every 5 min on a Centro LB960 plate luminometer.
Western blot analysis of PONs
To prepare total cell lysates, medium was aspirated, cells were washed with PBS and lysed by adding ice-cold lysis buffer [100 mM Tris/HCl, pH 7.4, 200 mM NaCl, 2 % Triton X-100 and Halt TM protease inhibitor (Pierce)], followed by 20 min of rocking at 4
• C and mechanical disruption. Lysates were centrifuged at 12 000 g for 30 min at 4
• C. Protein content was determined using the BCA method. Western blotting was performed according to standard procedures using a Semi-Dry Transfer Cell (BioRad Laboratories) and PVDF membranes. Rabbit anti-(human PON2) antibody was produced as described in [23] ; mouse anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was from Santa Cruz Biotechnology; mouse anti-tubulin was from Dianova; HRP (horseradish peroxidase)-conjugated secondary antibodies were from Sigma. Immunodetected proteins were visualized by Western Lightning chemiluminescence kit (PerkinElmer) using X-ray film exposure and were quantitatively evaluated with a ChemiDoc XRS imaging system (Bio-Rad Laboratories) equipped with QuantityOne 4.6.7 software.
For Western blot analysis of PON1, PON2 and PON3 in the A459 lysates shown in Figure 1 , the following procedure was used. Supernatants of cell lysates prepared for enzymatic analysis (above) were electrophoresed on 12 % Tris/HCl gels, transferred on to PVDF membranes, and blocked overnight. Immunoblot analysis of PON1 and PON2 were performed as described previously [17] . For PON3, the goat anti-PON3 primary antibody and HRP-conjugated anti-goat secondary antibody were from R&D Systems. Membranes were processed according to the manufacturer's protocol, except that the anti-PON3 primary antibody was used at a 1:800 dilution for 1 h and the secondary antibody was used at a 1:10000 dilution. Proteins were detected with HRP substrate (1-Step TMB Blotting; Pierce). Purified PONs were prepared as described previously [17] .
Quantification of PON2 mRNA
At the indicated time points, total RNA was extracted using the E.Z.N.A. ® total RNA kit (Omega Biotek). Then, 80 ng of RNA was used for cDNA generation using the High Capacity cDNA Reverse Transcription kit (Invitrogen) according to the manufacturer's instructions. RNA expression levels were 
Statistical analysis
Data were analysed using a one-way ANOVA or a two-tailed Student's t test.
RESULTS

3OC12 hydrolysis in A549 cellular lysates
We reported previously that hydrolysis of 3OC12 in EA.hy 926 and HepG2 cell lysates is catalysed by PON2, making it a good probe to assess PON2 hydrolytic activity in these cells [19] . In the present study, we demonstrate that PON2 is also the only enzyme in A549 cell lysates that hydrolyses 3OC12 to any appreciable extent. HPLC analysis show that the A549 cell lysates converted 3OC12 only into the corresponding 3OC12 acid product, i.e. no other peaks were apparent in the chromatograms and all of the lactone that was hydrolysed could be accounted for by the formation of the 3OC12 acid product (results not shown). This indicates that only 3OC12 lactonase activity was present in the lysates.
EDTA inhibits PONs by stripping them of their requisite structural and catalytic Ca 2+ ions [17] . When A549 cells were lysed in the presence of EDTA, no 3OC12 activity was detectable in the lysate, whereas in the absence of EDTA, the rate of 3OC12 hydrolysis was 4.9+ − 0.2 nmol/min per mg of protein. Because PON1 and PON3 also hydrolyse 3OC12, we examined the A549 lysates for the presence of these enzymes by Western blot analysis. As shown, PON1 and PON3 were not detectable in the lysates, detection limits being approx. <70 ng/mg of lysate for PON1 and <180 ng/mg of lysate for PON3 (Figure 2A) . PON2 was present at high levels, estimated to be over 325 ng/mg of lysate (Figure 2A) . To estimate the contribution of PON2 towards 3OC12 hydrolytic activity, cells were transfected with PON2-specific siRNAs and then lysates were analysed for 3OC12 hydrolytic activity. As seen in Figure 2 (B), PON2 protein expression is extensively decreased and PON2 protein mass very closely paralleled the decrease in the 3OC12 hydrolytic activity. The findings indicate that 3OC12 hydrolysis is a specific marker of PON2 hydrolytic activity in A549 cell lysates.
3OC12 down-regulates PON2 mRNA, protein and hydrolytic activity
Initial studies were performed with 100 μM 3OC12, which was soluble in the cell culture medium and was shown previously to elicit a relatively strong increase in cytosolic Ca 2+ in murine fibroblasts [21, 22] . To verify this effect for the cell lines used in the present study, EA.hy 926 and A549 cells were loaded with the Ca 2+ indicator Fluo-4 AM and were treated with 3OC12 or the ionophore A23187 (10 μM), as a positive control. Figures 3(A) and 3(B) show that both treatments caused a rapid and sustained increase in cytosolic Ca 2+ . As a control, and in contrast with the intact lactone, the open acid form of 3OC12, 3OC12 acid, did not cause Ca 2+ influx ( Figure 3C ). Because our previous data indicated an active degradation of PON2 mRNA and protein after disturbance of Ca 2+ homoeostasis [21] , we hypothesized that 3OC12, via Ca 2+ disturbance, causes PON2 degradation and/or inactivation. Indeed, treatment of A459 and EA.hy 926 cells with 3OC12 caused a decrease in PON2 mRNA levels ( Figure 3D ). mRNA decreased by 50-60 % in both cell lines, although in the A549 cells, the decreases did not occur until 8 h after treatment, whereas in the EA.hy 926 cells, the decrease occurred by 4 h. The mRNA remained low in the cell lines for at least 16 h ( Figure 3D ). In line with the assumption of a Ca 2+ -triggered mechanism, co-administration of the intracellular Ca 2+ chelator BAPTA/AM attenuated the 3OC12-induced PON2 mRNA degradation ( Figure 3E ). Likewise, PON2 protein decreased gradually between 0.5 and 8 h after 3OC12 treatment, reaching an approx. 50 % decrease by 8 h in both cell lines ( Figure 3F) . A 50 μM treatment of A549 cells with 3OC12 also significantly decreased PON2 protein Significance was tested by one-way ANOVA; n=3-8; n.s., not significant; *P < 0.05; **P < 0.01; ***P < 0.001. levels; however, increasing the 3OC12 concentration from 100 to 200 μM did not result in a greater decrease in protein after a 1 h treatment ( Figure 3G ). The Ca 2+ chelator BAPTA/AM also attenuated the 3OC12-mediated decrease in PON2 protein ( Figure 3H ). We demonstrated previously that PON2 mRNA and protein are very stable (i.e. they have half lives of over 24 h) [21] and that Ca 2+ mediates an active degradation of the mRNA and protein. Results presented here are consistent with these previous findings and indicate that 3OC12 also mediates an active degradation of PON2 mRNA and protein via increased Ca 2+ influx. The decrease in PON2 hydrolytic activity by 3OC12, as measured by 3OC12 hydrolysis in the cell lysates, was much more rapid and extensive than the decreases in protein and mRNA ( Figure 4A ). The A549 cells were more sensitive to PON2 activity decrease than the EA.hy 926 cells. As early as 2 min after treatment of the A549 cells, PON2 activity had decreased by 75 % compared with untreated cells; yet levels of PON2 protein were unaffected (results not shown). Interestingly, although the protein continued to decrease up to 8 h after treatment, the last time point analysed for protein, the activity increased between 5 and 25 h in both cell lines ( Figure 4A ). Taken together, the data demonstrate that the decrease of PON2 activity mediated by 3OC12 cannot be fully accounted for by the decrease in protein, suggesting instead a rapid and reversible post-translational modification of PON2 affecting its hydrolytic activity.
The effect of 3OC12 on PON2 hydrolytic activity was dose-dependent ( Figure 4B ). After only 10 min, the lowest concentration of 3OC12 tested, 12.5 μM, was able to significantly decrease PON2 activity in both A549 and EA.hy 926 cell lines, although, at higher concentrations, the A549 cells were more sensitive to 3OC12. We also tested the ability of 3OC12 to decrease PON2 activity in EA.hy 926 cells stably overexpressing a PON2-GFP (green fluorescent protein) construct. These cells have approx. 2.5-fold as much PON2 as naïve EA.hy 926 cells as determined by both 3OC12 hydrolysis activity and protein mass (results not shown) [23] . The 3OC12 (at 50 μM) activity is 1.5, 4.3 and 7.2 nmol/min per mg in naïve EA.hy 926 cell, PON2-GFP EA.hy 926 cell and A549 cell lysates respectively. The PON2-GFP-overexpressing cells were more sensitive to the 3OC12-mediated decrease in PON2 activity than the naïve cells and exhibited a similar dose-response relationship as the A549 cells ( Figure 4B ). Previous studies have shown that it is the lactone form of the natural L-isomer of 3OC12 that is biologically active. We also found that only the L-isomer of 3OC12 was able to decrease PON2 activity and protein ( Figure 4C ). Additionally, as expected, treatment of the cells with the open acid form of 3OC12 had no effect on PON2 activity ( Figure 4C ).
To determine whether the decrease in PON2 hydrolytic activity was also mediated by Ca 2+ , A549 cells were treated with the ionophore A23187 and then the lysates were analysed for PON2 activity. A 10 min treatment with A23187 caused a dosedependent decrease in PON2 activity in a dose range that caused a rapid increase in cytosolic Ca 2+ ( Figures 3B and 5A ). When A549 cells were loaded with the Ca 2+ chelator BAPTA/AM and then treated with 3OC12, a significant protection from PON2 activity decrease was observed, although protection was not complete ( Figure 5B ). It is possible that BAPTA/AM could have completely protected PON2 activity from the 3OC12-mediated decrease; however, at concentrations above 10 μM, BAPTA/AM alone had inhibitory affects on PON2 activity ( Figure 5B ). The higher BAPTA/AM concentrations may have inactivated PON2 because PON2 requires Ca 2+ for its stability and hydrolytic activity. The viability of the A549 cells was not affected by treatment with 100 μM 3OC12 up to 5 h, but did decrease slightly at 16 Figure 4 The L-isomer of 3OC12 mediates decreases in PON2 hydrolytic activity and protein (A, B) Cells were treated with 100 μM 3OC12 for the durations indicated (A) or increasing concentrations of 3OC12 for 10 min (B), and cell lysates then analysed for PON2 activity. (C) A549 cells were treated with 100 μM of the compound shown for 10 min and cell lysates were analysed for PON2 activity, or for 8 h and cell lysates were analysed for PON2 protein levels. Results are the means+S.D. of at least three replicate analyses. Significance was tested by a two-tailed Student's t test; *P < 0.05; **P < 0.01; ***P < 0.001. and 25 h, whereas the viability of the naïve or PON2-GFPoverexpressing EA.hy 926 cells was not significantly affected up to 16 h, but decreased slightly by 24 h (Figure 6A ). 3OC12 is known to induce apoptosis in numerous cell lines and we also found that 3OC12 induced caspase 3/7 activation, a mediator of apoptosis, in the EA.hy 926 cells ( Figure 6B ). Although caspase 3/7 activation was lower in the PON2-GFP cells, the decrease was not significant. The lack of significant protection from 3OC12-mediated loss of viability and caspase activation by higher levels of PON2 in the PON2-GFP cells is possibly due to the rapid decreases of PON2 activity and/or protein mediated by 3OC12.
PON2 protects cells from ROS induced by PCN
We found previously that PON2 decreased the production of ROS after treatment of EA.hy 926 cells with the redox-cycling compound DMNQ [23] . Therefore we also wanted to test whether PON2 could attenuate ROS production by PCN. ROS generation was measured by preloading cells with carboxy-H 2 DCFDA, a non-specific intracellular indicator of ROS, and then treating with PCN. PCN was a potent inducer of ROS in both EA.hy 926 and A549 cells, inducing ROS at a concentration of 2.4 μM, the lowest concentration tested (Figures 7A and 7B) . To test the potential contribution of PON2 to protect against ROS generation, cells were transfected with PON2-specific siRNA and then analysed for ROS generation after PCN treatment. Transfection with siRNA decreased the PON2 mass by an average of 73+ − 5 % relative to controls in both cell lines (shown for A549 cells in Figure 7C ). EA.hy 926 and A549 cells treated with the PON2-specific siRNA produced significantly more ROS than cells treated with nonspecific scrambled siRNA after treatment with 2.4 μM PCN (Figures 7D and 7E) . Conversely, cells overexpressing PON2-GFP were treated with PCN to see whether they were more resistant to ROS production. At concentrations of PCN below 48 μM, the EA.hy 926 PON2-GFP cells were more resistant to ROS production than EA.hy 926 cells; however, at higher concentrations, the PON2-GFP cells were equally susceptible to ROS production ( Figures 8A-8C ). Under our conditions, the limit for protection in the EA.hy 926 PON2-GFP cells was approx. 50 μM PCN. These findings suggest that PON2 can protect cells from oxidation induced by PCN, as has been shown previously for other redox-cycling compounds. To exclude a possible direct oxidation of the fluorescent dye carboxy-H 2 DCFDA by PCN and to control for effects of the GFP tag of PON2, ROS was also reported by the luminol derivative L-012 in EA.hy 926 cells stably overexpressing a PON2-HA (haemagglutinin) construct. As with PON2-GFP cells, the PON2-HA cells express approximately twice as much PON2 and naïve cells [23] . As before, PCN (24 μM) produced significantly more ROS in naïve cells than in PON2-HA-overexpressing cells ( Figure 8E ). Direct exposure of PCN to L-012 without cells did not produce an increase in chemiluminescence (results not shown). It should be noted that although levels of ROS induction varied somewhat between experiments, the relative effects of PON2 decrease or overexpression remained unchanged. (A, B, D and E) . In D and E, curve maxima calculated by non-linear regression showed statistically significant differences (P < 0.001).
Figure 8 PON2-overexpressing cells are more resistant to PCN-induced ROS formation
Carboxy-H 2 DCFDA-loaded naïve EA.hy 926 cells (grey traces) or cells stably overexpressing PON2-GFP (black traces) were treated with increasing concentrations of PCN of 0.5, 5, 10 or 20 μg/ml (equalling 2.4, 24, 48 and 96 μM; A-D respectively). Naïve (grey traces) or PON2-HA-overexpressing (black traces) EA.hy 926 cells were loaded with luminol derivative L-012 and stimulated with 24 μM PCN (E). Chemiluminescence, as an indicator of ROS production, was recorded at 5 min intervals for 4 h. In (A), (B) and (E), but not (C) and (D), curve maxima calculated by non-linear regression showed statistically significant differences (P < 0.001). . Fluorescence intensity as means of ROS was recorded for 12 h. In (A) and (B), when using 50 μM 3OC12 or greater, curve maxima calculated by non-linear regression showed statistically significant differences (P < 0.01; P < 0.001).
3OC12 potentiates the formation of ROS induced by PCN
During Ps. aeruginosa infection, host cells are likely to be coexposed to 3OC12 and PCN. Given the ability of 3OC12 to downregulate PON2, we tested whether 3OC12 could potentiate PCNmediated ROS generation. The EA.hy 926 PON2-GFP and A549 cells were very sensitive to potentiation of PCN-mediated ROS generation by 3OC12. A 3OC12 concentration as low as 25 μM significantly potentiated ROS formation by PCN, a concentration which also significantly decreased PON2 hydrolytic activity in these two cell lines ( Figures 4B, 9A and 9B). As described above, the EA.hy 926 cells are not as sensitive to the decrease in PON2 hydrolytic activity as the PON2-GFP and A549 cells and were also not as sensitive to 3OC12 potentiation of PCN-mediated ROS formation ( Figure 9C ). Although ROS generation in EA.hy 926 cells co-treated with 100 μM 3OC12 and 2.4 μM PCN was slightly higher than ROS levels in cells treated with PCN alone, the difference was not statistically significant ( Figure 9C ). In general, the concentrations of 3OC12 that potentiated PCN-mediated ROS formation appeared to be inversely proportional to the 3OC12 concentrations that caused decreases in PON2 hydrolytic activity.
DISCUSSION
Ps. aeruginosa infections are difficult to treat owing to the bacterium's ability to acquire antibiotic resistance and evade the host's immune responses. Thus there has been a great effort to understand Ps. aeruginosa pathogen-host interactions so that novel therapeutic targets can be identified. Using human A549 and EA.hy 926 cell lines, we have demonstrated that PON2 attenuates ROS production induced by the Ps. aeruginosa virulence factor PCN. Additionally, we have shown that the Ps. aeruginosa quorum-sensing signal 3OC12, which is inactivated by PON2, down-regulates PON2 mRNA, protein and hydrolytic activity. These decreases were at least partly mediated by increases in cytosolic Ca 2+ . The hydrolytic activity of PON2 was decreased much more extensively and rapidly than the protein, indicating a likely post-translational event which blocks PON2's hydrolytic activity. This is the first demonstration of a rapid post-translational modification of any PON family member which alters its activity and suggests a function for PON2 that requires rapid and dynamic regulation. These findings support a role for PON2 in the defence against Ps. aeruginosa virulence, but also reveal a potential mechanism by which the bacterium may subvert the protection afforded by PON2.
The nature of the putative post-translational modification is unknown, but appears to be reversible because hydrolytic activity of PON2 begins to rebound over time, whereas protein levels stay diminished ( Figure 4A ). The observed decrease of PON2's hydrolytic activity by the Ca 2+ ionophore A23187 and attenuation of this decrease by the Ca 2+ chelator BAPTA/AM indicates that this putative modification is mediated by Ca 2+ . Ca 2+ was shown previously to be released from the endoplasmic reticulum and mediate apoptosis in fibroblasts treated with 3OC12 [22] . Ca 2+ is very commonly employed as a second messenger for cell signal transduction, regulating a large and diverse array of cellular processes such as gene expression and protein function [24] . The PON2 paralogue, PON1, was shown previously to undergo a glutathionylation of its free cysteine residue(s), which resulted in its inactivation after incubation with high (millimolar) concentrations of oxidized glutathione (GSSG) [25] . This is unlikely to be occurring with PON2 in our system, as inactivation with GSSG required longer incubation times and Ca 2+ would not be expected to mediate a rapid and prolonged induction of GSSG. The rapid and reversible nature of the putative modification would be consistent with phosphorylation/dephosphorylation by protein kinases/phosphatases. However, protein function can be modified by a diverse and dynamic array of modifications, including methylation, acetylation, ubiquitination, glycosylation/ deglycosylation and many others. The nature of the modification and whether similar modifications occur with other PONs remain to be determined.
Up to 600 μM 3OC12 have been reported in Ps. aeruginosa biofilms grown in vitro [26] , which is well above concentrations that we found were able to decrease both PON2 hydrolytic activity and protein. This suggests that near sites of colonization, 3OC12 may be well within the range to extensively suppress PON2. Other Ps. aeruginosa virulence factors including flagellin, as well as PCN, have been shown to induce cytosolic Ca 2+ influx [27, 28] . Thus, in addition to 3OC12, these factors may also contribute to Ca 2+ -mediated PON2 down-regulation resulting in a diminished ability of cells to inactivate 3OC12 and higher local 3OC12 concentrations. This could not only promote a more robust expression of bacterial virulence, but also render the tissue more sensitive to the immunomodulatory actions of 3OC12.
Our finding that PON2 hydrolytic activity is rapidly and extensively decreased by 3OC12 could explain the results by Stoltz et al. [20] , i.e. that intact epithelial cells from PON2-deficient and wild-type mice inactivate 3OC12 at the same rate. However, the 3OC12 concentration used in their study was 10 μM, below the concentrations we found to appreciably decrease PON2 in the human EA.hy 926 and A549 cells. Previous studies have shown that 3OC12 at concentrations of 10 μM and lower can induce apoptosis, inflammatory gene expression and immunosuppressive effects in some non-immortalized cells [22, 29, 30] . Thus it is possible that the primary bronchial epithelial cells studied by Stoltz et al. [20] are more sensitive to 3OC12-mediated PON2 down-regulation than the cells used in the present study.
Oxidative stress induced by PCN has been shown to cause dysfunction in many different cell types, including airway epithelial cells and endothelial cells. In the present study, we demonstrate in epithelial and endothelial cell lines that decreasing PON2 levels exacerbates, whereas overexpression of PON2 attenuates, PCN-mediated ROS production, providing evidence that PON2 can protect against oxidative stress induced by PCN. The mechanism by which PON2 mediates its antioxidant function(s) is not clear. However, we found recently that PON2 specifically decreased intracellular superoxide levels, but not of hydrogen peroxide or peroxynitrite (S. Horke, unpublished work). The decreases in superoxide levels appeared to be independent of PON2's lactonase activity, cellular superoxide dismutase activity or alterations in GSH/GSSG ratios. PCN has been shown to form superoxide, as well as hydrogen peroxide (presumably as a dismutation product of superoxide), in cell cultures [11] and decreases in superoxide by PON2 would probably occur during PCN exposure.
The ability of PON2 to attenuate ROS formation by PCN in the EA.hy 926 PON2-GFP-overexpressing cells was lost at concentrations of 50 μM and greater. ROS have been shown to inactivate the antioxidative function of PON1 [31] . It is possible that, at these higher ROS concentrations, PON2's antioxidative function is also inactivated or PON2 may not have the capacity to efficiently inactivate such high concentrations of ROS. PCN at concentrations of 80 μM and greater have been shown to raise cytosolic Ca 2+ levels in A549 cells [30] . It is also possible that, in our experiments, the inability to detect any protection from PON2 at PCN concentrations of 50 μM and greater is due to a decrease in PON2 protein and/or hydrolytic activity resulting from a PCN-mediated Ca 2+ increase. The concentration of PCN at sites of bacterial colonization is not known; however, concentrations of 2.7-25 μM have been detected in exudates from infected wounds, and concentrations up to 130 μM have been detected in sputum from individuals with lung infections [32] . This suggests that at sites proximal to colonization, PCN may reach concentrations which exceed the ability of PON2 to provide sufficient protection from ROS generation. However, at sites more distant from the colonization sites, and at the early phases of infection, concentrations of PCN would probably be lower and PON2 may help to protect these cells from PCNmediated oxidative stress.
Additionally, we have shown that PCN-mediated ROS generation in cell cultures was potentiated by 3OC12. Little is known about the potential of 3OC12 to alter the antioxidant status of cells. The inverse association between 3OC12-mediated decrease in PON2 and potentiation of ROS formation by PCN supports the supposition that 3OC12 potentiates ROS formation by decreasing PON2. Because the mechanism by which PON2 attenuates oxidative stress is unknown, it is not clear whether decreases in PON2 protein, hydrolytic activity or both by 3OC12 contribute to potentiation of ROS formation. PCN is a zwitterion that easily penetrates biological membranes and would be expected to rapidly enter cells and begin generating ROS. The rapid decrease of PON2 hydrolytic activity, but not protein, by 3OC12 may suggest that putative modification which blocks PON2's hydrolytic activity may also block its antioxidative function.
Interestingly, compared with the EA.hy 926 PON2-GFP and A549 cells, the naïve EA.hy 926 cells, which express PON2 at significantly lower levels, were not as sensitive to 3OC12 potentiation of PCN-mediated ROS formation and were also not as sensitive to a decrease in PON2 activity by 3OC12. Further detailed studies are necessary to demonstrate conclusively that 3OC12 potentiates PCN ROS formation by decreasing PON2 levels and to determine whether the putative modification of PON2 that blocks its hydrolytic activity also will block its antioxidative activity.
Ps. aeruginosa virulence is mediated by a dynamic expression of a large number of virulence factors. The multiplicity of these factors, their time-dependent expression and reciprocal actions severely complicates interpretation of their effects during in vivo infections. Using purified products of the bacteria, we were able to directly demonstrate that 3OC12 can down-regulate PON2 through induction of cytosolic Ca 2+ and that cellular PON2 confers protection against PCN-mediated oxidative stress. Ca 2+ is a common mediator of cell signalling events and it is possible that other Ps. aeruginosa factors, as well as host inflammatory mediators induced during bacterial infection, may affect the regulation of PON2. Important future studies will be to extend our studies to investigate the effects Ps. aeruginosa has on PON2 during infection. Also, identification of the post-translational modification of PON2 and the signalling pathways that mediate PON2 down-regulation may lead to an important therapeutic approach which blocks the 3OC12 and Ca 2+ -mediated decrease in PON2 protein and/or activity. A therapy which blocks the downregulation of PON2 could greatly enhance the ability of the host to protect against Ps. aeruginosa virulence and also to protect against oxidative stress in general.
